The Effects of Disease-Modifying Antirheumatic Drugs on Cardiovascular Risk in Inflammatory Joint Diseases: Current Evidence and UncertaintiesOlena Garmish, Roman Komorovsky, Fedir Hladkykh et al.|Vascular Health and Risk Management|2025Cited by 9